Sakar Healthcare (SAKAR)
FAST GROWERFairStock Score: 34/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹633.65 |
| Market Cap | ₹1,100.48 Cr |
| P/E Ratio | 43.64 |
| ROCE | 8.54% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 124.29% |
| Debt/Equity | 0.28 |
| Sales Growth | 62% |
| Promoter Holding | 52.86% |
| 52-Week Range | ₹306.35 — ₹871.3 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹136.29 |
Sakar Healthcare trades with a P/E ratio of 43.64, ROCE of 8.54%, profit growth of 124.29%, debt-to-equity of 0.28. The FairStock Score of 34/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer